638 related articles for article (PubMed ID: 18509186)
1. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.
Coiffier B; Altman A; Pui CH; Younes A; Cairo MS
J Clin Oncol; 2008 Jun; 26(16):2767-78. PubMed ID: 18509186
[TBL] [Abstract][Full Text] [Related]
2. An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome.
Mughal TI; Ejaz AA; Foringer JR; Coiffier B
Cancer Treat Rev; 2010 Apr; 36(2):164-76. PubMed ID: 20031331
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.
Cairo MS; Coiffier B; Reiter A; Younes A;
Br J Haematol; 2010 May; 149(4):578-86. PubMed ID: 20331465
[TBL] [Abstract][Full Text] [Related]
4. Tumour lysis syndrome: new therapeutic strategies and classification.
Cairo MS; Bishop M
Br J Haematol; 2004 Oct; 127(1):3-11. PubMed ID: 15384972
[TBL] [Abstract][Full Text] [Related]
5. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
Baeksgaard L; Sørensen JB
Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
[TBL] [Abstract][Full Text] [Related]
6. Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panel.
Pession A; Masetti R; Gaidano G; Tosi P; Rosti G; Aglietta M; Specchia G; Porta F; Pane F
Adv Ther; 2011 Aug; 28(8):684-97. PubMed ID: 21779956
[TBL] [Abstract][Full Text] [Related]
7. Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management.
Abu-Alfa AK; Younes A
Am J Kidney Dis; 2010 May; 55(5 Suppl 3):S1-13; quiz S14-9. PubMed ID: 20420966
[TBL] [Abstract][Full Text] [Related]
8. The management of tumor lysis syndrome.
Rampello E; Fricia T; Malaguarnera M
Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389
[TBL] [Abstract][Full Text] [Related]
9. Tumor lysis syndrome in elderly.
Pumo V; Sciacca D; Malaguarnera M
Crit Rev Oncol Hematol; 2007 Oct; 64(1):31-42. PubMed ID: 17658268
[TBL] [Abstract][Full Text] [Related]
10. [Tumor lysis syndrome].
Hagino T
Gan To Kagaku Ryoho; 2010 Jun; 37(6):984-8. PubMed ID: 20567098
[TBL] [Abstract][Full Text] [Related]
11. [Rasburicase versus allopurinol in the treatment of hyperuricaemia in tumour lysis syndrome].
Tatay VS; Castilla JD; Ponce JM; Hurtado JM; Cantero E; Abril ML
An Pediatr (Barc); 2010 Feb; 72(2):103-10. PubMed ID: 20022572
[TBL] [Abstract][Full Text] [Related]
12. Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia.
Cheson BD
Clin Adv Hematol Oncol; 2009 Apr; 7(4):263-71. PubMed ID: 19521331
[TBL] [Abstract][Full Text] [Related]
13. [Tumor lysis syndrome and clinical guidelines].
Ishizawa K
Gan To Kagaku Ryoho; 2014 Feb; 41(2):135-40. PubMed ID: 24743190
[TBL] [Abstract][Full Text] [Related]
14. Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome.
Kennedy LD; Ajiboye VO
J Oncol Pharm Pract; 2010 Sep; 16(3):205-13. PubMed ID: 19923162
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China.
Hu S; Han Y; Zhang W; Zhang T; Yao X; Liu L
J Med Econ; 2019 Aug; 22(8):742-750. PubMed ID: 30939962
[No Abstract] [Full Text] [Related]
16. Rasburicase: a new approach for preventing and/or treating tumor lysis syndrome.
Bessmertny O; Robitaille LM; Cairo MS
Curr Pharm Des; 2005; 11(32):4177-85. PubMed ID: 16375739
[TBL] [Abstract][Full Text] [Related]
17. Treatment of tumor lysis syndrome with the highest known uric acid level.
Ozkan G; Ulusoy S; Sönmez M; Kaynar K; Karagülle M
Ren Fail; 2010; 32(7):895-8. PubMed ID: 20662707
[TBL] [Abstract][Full Text] [Related]
18. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
Hussain K; Mazza JJ; Clouse LH
Am J Hematol; 2003 Mar; 72(3):212-5. PubMed ID: 12605395
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome.
Davidson MB; Thakkar S; Hix JK; Bhandarkar ND; Wong A; Schreiber MJ
Am J Med; 2004 Apr; 116(8):546-54. PubMed ID: 15063817
[TBL] [Abstract][Full Text] [Related]
20. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome.
Truong TH; Beyene J; Hitzler J; Abla O; Maloney AM; Weitzman S; Sung L
Cancer; 2007 Oct; 110(8):1832-9. PubMed ID: 17724682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
